Arno Therapeutics, Inc 4
4 · Arno Therapeutics, Inc · Filed Apr 11, 2016
Insider Transaction Report
Form 4
HAMILTON WILLIAM F PHD
Director
Transactions
- Award
Stock Option (right to buy)
2016-04-07+88,628→ 88,628 totalExercise: $0.37Exp: 2026-04-07→ Common Stock (88,628 underlying)
Holdings
- 22,079
Common Stock
- 3,750
Stock Option (right to buy)
Exercise: $8.00Exp: 2019-09-29→ Common Stock (3,750 underlying) - 34,224
Stock Option (right to buy)
Exercise: $2.90Exp: 2024-01-24→ Common Stock (34,224 underlying) - 1,250
Stock Option (right to buy)
Exercise: $8.00Exp: 2020-11-05→ Common Stock (1,250 underlying) - 38,940
2013 Series D Warrants (right to buy)
Exercise: $2.14From: 2013-10-29Exp: 2018-10-29→ Common Stock (38,940 underlying) - 68,448
Stock Option (right to buy)
Exercise: $2.40Exp: 2023-11-04→ Common Stock (68,448 underlying)
Footnotes (4)
- [F1]Currently exercisable.
- [F2]Vests in equal 36-monthly installments commencing 12/4/13.
- [F3]Vests in equal 12-monthly installments commencing 5/7/16.
- [F4]As a result of the Issuer's 1/12/16 private placement of common stock at $0.35/share, the exercise price and number of shares subject to the 2013 Series D Warrants were automatically adjusted to the exercise price and shares reflected, pursuant to anti-dilution adjustment provisions.